Christopher S. Grubb

Christopher S. Grubb

Auto-generated profile, based on publicly available information

Christopher S. Grubb

Department of Medicine, Columbia University Irving Medical Center, New York, NY

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
CGChristopher S. Grubb
Christopher S. Grubb
LMLea Melki
Lea Melki
DWDaniel Y. Wang
Daniel Y. Wang
JPJames Peacock
James Peacock
JDJose Dizon
Jose Dizon
EWElaine Y. Wan
Elaine Y. Wan
Cardiac arrhythmias are a major cause of morbidity and mortality worldwide. The 12-lead electrocardiogram (ECG) is the current noninvasive clinical tool used to diagnose and localize cardiac arrhythmias. However, it has limited accuracy and is subject to operator bias. Here, we present electromechanical wave imaging (EWI), a high–frame rate ultrasound technique that can noninvasively map with high accuracy the electromechanical activation of atrial and ventricular arrhythmias in adult patients. This study evaluates the accuracy of EWI for localization of various arrhythmias in all four chambers of the heart before catheter ablation. Fifty-five patients with an accessory pathway (AP) with Wolff-Parkinson-White (WPW) syndrome, premature ventricular complexes (PVCs), atrial tachycardia (AT), or atrial flutter (AFL) underwent transthoracic EWI and 12-lead ECG. Three-dimensional (3D) rendered EWI isochrones and 12-lead ECG predictions by six electrophysiologists were applied to a standardized segmented cardiac model and subsequently compared to the region of successful ablation on 3D electroanatomical maps generated by invasive catheter mapping. There was significant interobserver variability among 12-lead ECG reads by expert electrophysiologists. EWI correctly predicted 96% of arrhythmia locations as compared with 71% for 12-lead ECG analyses [unadjusted for arrhythmia type: odds ratio (OR), 11.8; 95% confidence interval (CI), 2.2 to 63.2; P = 0.004; adjusted for arrhythmia type: OR, 12.1; 95% CI, 2.3 to 63.2; P = 0.003]. This double-blinded clinical study demonstrates that EWI can localize atrial and ventricular arrhythmias including WPW, PVC, AT, and AFL. EWI when used with ECG may allow for improved treatment for patients with arrhythmias.

3 July 2017 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
ASAnurag Saraf
Anurag Saraf
CGChristopher S. Grubb
Christopher S. Grubb
MHMark E. Hwang
Mark E. Hwang
CTCheng-Hung Tai
Cheng-Hung Tai
CWCheng-Chia Wu
Cheng-Chia Wu
TWTony Wang
Tony Wang

28 November 2015 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
CGChristopher S. Grubb
Christopher S. Grubb
AJAshish Jani
Ashish Jani
CWCheng-Chia Wu
Cheng-Chia Wu
SSShumaila Saad
Shumaila Saad
YQYasir H. Qureshi
Yasir H. Qureshi
TWTony Wang
Tony Wang

1 September 2016 in Practical Radiation Oncology
Verified
Journal Article
Closed access
TWTony Wang
Tony Wang
CWCheng-Chia Wu
Cheng-Chia Wu
AJAshish Jani
Ashish Jani
JEJuan Estrada
Juan Estrada
TUTimothy Ung
Timothy Ung
GMGuy M. McKhann
Guy M. McKhann

10 October 2017 in Molecules
Verified
Journal Article
Open access
PDF file
SMSarah N. Malkowski
Sarah N. Malkowski
CDCarolyn F. Dishuck
Carolyn F. Dishuck
GLGene G. Lamanilao
Gene G. Lamanilao
CECarter Embry
Carter Embry
CGChristopher S. Grubb
Christopher S. Grubb
LPLarryn Peterson
Larryn Peterson
Copper-catalyzed azide-alkyne cycloadditions (CuAAC or click chemistry) are convenient methods to easily couple various pharmacophores or bioactive molecules. A new series of 1,2,3-triazole-linked nucleoside-amino acid conjugates have been designed and synthesized in 57–76% yields using CuAAC. The azido group was introduced on the 5′-position of uridine or the acyclic analogue using the tosyl-azide exchange method and alkylated serine or proparylglycine was the alkyne. Modeling studies of the conjugates in the active site of LpxC indicate they have promise as antibacterial agents.

31 January 2018 in CNS Oncology
Verified
Journal Article
Open access
CTCheng-Hung Tai
Cheng-Hung Tai
CWCheng-Chia Wu
Cheng-Chia Wu
MHMark E Hwang
Mark E Hwang
ASAnurag Saraf
Anurag Saraf
CGChristopher Grubb
Christopher Grubb
TWTony Wang
Tony Wang
Aim: The number of breast cancer brain metastases is a prognostic clinical variable in the modified graded prognostic assessment (GPA) Index for breast cancer. Patients & methods: We retrospectively gathered data from 127 breast cancer patients who underwent radiation therapy for brain metastasis. Patients were stratified by both breast GPA and modified breast GPA scores, and survival was determined using the Kaplan–Meier curves and Cox proportional hazards model. Results & Conclusion: The Kaplan–Meier curve for patients under the breast GPA classification were not significant, but were significant under the modified breast GPA classification. The inclusion of number of brain metastases into the modified breast GPA index improved prognosis, thus validating the use of the modified breast GPA in prognosticating patient outcome.